Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. WDAY
2. ESTC
3. AFRM
4. MRVL
5. RBRK
6. S
7. ULTA
8. GAP
9. DG
10. ADSK

Go back to Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients
(NASDAQ: TLSA) Delayed: 1.08 --0 (-0%)
Previous Close $1.08    52 Week High $ 
Open $1.08    52 Week Low $ 
Day High $1.08    P/E N/A 
Day Low $1.08    EPS $ 
Volume 1,582